Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc. (PBLA) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 22 transactions totaling $51.7K, demonstrating a bearish sentiment with -$51.7K in net insider flow. The most recent transaction on Nov 8, 2023 involved a sale of 72,874 shares valued at $51.7K.
PBLA Insider Activity Summary
Who Is Buying PBLA Stock?
No significant insider buying has been recorded for PBLA in the recent period.
Who Is Selling PBLA Stock?
No significant insider selling has been recorded for PBLA in the recent period.
Is Panbela Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PBLA is bearish with an Insider Alignment Score of 0/100 and a net flow of -$51.7K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PBLA Frequently Asked Questions
Understanding PBLA Insider Activity
Insider trading at Panbela Therapeutics, Inc. (PBLA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading PBLA stock, having executed 22 transactions in the past 90 days. The most active insider is Sachs &. Co. Llc Goldman (Executive), who has made 1 transactions totaling $51.7K.
Related Tools
Track Panbela Therapeutics, Inc. Insider Activity
Get notified when executives and directors at PBLA file new Form 4 transactions